These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 7533747)

  • 21. Effects of magainins on ameba and cyst stages of Acanthamoeba polyphaga.
    Schuster FL; Jacob LS
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1263-71. PubMed ID: 1416825
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro susceptibility of pathogenic Naegleria and Acanthamoeba speicies to a variety of therapeutic agents.
    Duma RJ; Finley R
    Antimicrob Agents Chemother; 1976 Aug; 10(2):370-6. PubMed ID: 984777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Encystation in Acanthamoeba castellanii: development of biocide resistance.
    Lloyd D; Turner NA; Khunkitti W; Hann AC; Furr JR; Russell AD
    J Eukaryot Microbiol; 2001; 48(1):11-6. PubMed ID: 11249185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Weak cytotoxic activity of miltefosine against clinical isolates of Acanthamoeba spp.
    Mrva M; Garajová M; Lukáč M; Ondriska F
    J Parasitol; 2011 Jun; 97(3):538-40. PubMed ID: 21506779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug resistance and Acanthamoeba keratitis: the quest for alternative antiprotozoal chemotherapy.
    Hay J; Kirkness CM; Seal DV; Wright P
    Eye (Lond); 1994; 8 ( Pt 5)():555-63. PubMed ID: 7835453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Polyamine content of Acanthamoeba polyphaga at different stages of development and the effect of pentamidine.
    Asiri SA; Ogbunude PO; Warhurst DC
    Adv Exp Med Biol; 1994; 370():503-8. PubMed ID: 7660957
    [No Abstract]   [Full Text] [Related]  

  • 27. Bacteriocin-like substance from Bacillus amyloliquefaciens shows remarkable inhibition of Acanthamoeba polyphaga.
    Benitez LB; Caumo K; Brandelli A; Rott MB
    Parasitol Res; 2011 Mar; 108(3):687-91. PubMed ID: 20967460
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of caspofungin on trophozoites and cysts of three species of Acanthamoeba.
    Bouyer S; Imbert C; Daniault G; Cateau E; Rodier MH
    J Antimicrob Chemother; 2007 Jan; 59(1):122-4. PubMed ID: 17079240
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amoebicidal or amoebostatic influence of disinfectants used in health facilities and laboratories on corneal strains of Acanthamoeba.
    Baltaza W; Padzik M; Szaflik JP; Dybicz M; Hendiger E; Chomicz L
    Ann Parasitol; 2017; 63(3):167-172. PubMed ID: 29274209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emergence of resistance to biocides during differentiation of Acanthamoeba castellanii.
    Turner NA; Russell AD; Furr JR; Lloyd D
    J Antimicrob Chemother; 2000 Jul; 46(1):27-34. PubMed ID: 10882685
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro amoebicidal activity of propolis on Acanthamoeba castellanii.
    Topalkara A; Vural A; Polat Z; Toker MI; Arici MK; Ozan F; Cetin A
    J Ocul Pharmacol Ther; 2007 Feb; 23(1):40-5. PubMed ID: 17341149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Amoebicidal Activity of Caffeine and Maslinic Acid by the Induction of Programmed Cell Death in Acanthamoeba.
    Martín-Navarro CM; López-Arencibia A; Sifaoui I; Reyes-Batlle M; Fouque E; Osuna A; Valladares B; Piñero JE; Héchard Y; Maciver SK; Lorenzo-Morales J
    Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28320723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and in vitro activity of new biguanide-containing dendrimers on pathogenic isolates of Acanthamoeba polyphaga and Acanthamoeba griffini.
    Martín-Pérez T; Lozano-Cruz T; Criado-Fornelio A; Ortega P; Gómez R; de la Mata FJ; Pérez-Serrano J
    Parasitol Res; 2019 Jun; 118(6):1953-1961. PubMed ID: 31069536
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative effects of selected azole compounds on trophic and cystic stages of Acanthamoeba polyphaga.
    Schuster FL
    J Eukaryot Microbiol; 1993; 40(5):563-9. PubMed ID: 8401469
    [No Abstract]   [Full Text] [Related]  

  • 35. A keratitis rat model for evaluation of anti-Acanthamoeba polyphaga agents.
    Vasseneix C; Gargala G; François A; Hellot MF; Duclos C; Muraine M; Benichou J; Ballet JJ; Brasseur G; Favennec L
    Cornea; 2006 Jun; 25(5):597-602. PubMed ID: 16783150
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fate of internalized Campylobacter jejuni and Mycobacterium avium from encysted and excysted Acanthamoeba polyphaga.
    Maal-Bared R; Dixon B; Axelsson-Olsson D
    Exp Parasitol; 2019 Apr; 199():104-110. PubMed ID: 30902623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced killing of Acanthamoeba cysts in vitro using dimethylsulfoxide.
    Saunders PP; Proctor EM; Rollins DF; Richards JS
    Ophthalmology; 1992 Aug; 99(8):1197-200. PubMed ID: 1513571
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Anti-plasmodial and anti-leishmanial activity of conformationally restricted pentamidine congeners.
    Huang TL; Vanden Eynde JJ; Mayence A; Donkor IO; Khan SI; Tekwani BL
    J Pharm Pharmacol; 2006 Aug; 58(8):1033-42. PubMed ID: 16872549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterisation of pentamidine-resistant Trypanosoma brucei brucei.
    Berger BJ; Carter NS; Fairlamb AH
    Mol Biochem Parasitol; 1995 Feb; 69(2):289-98. PubMed ID: 7770092
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro evaluation of the effectiveness of the macrolide rokitamycin and chlorpromazine against Acanthamoeba castellanii.
    Mattana A; Biancu G; Alberti L; Accardo A; Delogu G; Fiori PL; Cappuccinelli P
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4520-7. PubMed ID: 15561820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.